Bobillo S, Joffe E, Lavery JA, et al. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era. Blood. 2021;137(1):39-48.

doi:10.1182/blood.2021015316

In “Acknowledgments” on page 47, National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30CA008748 should have been cited. The error has been corrected in the online version of the article.

2022

Sign in via your Institution

Bobillo S, Joffe E, Lavery JA, et al. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era. Blood. 2021;137(1):39-48.

Cited By

Email alerts

ASH Publications

American Society of Hematology

Bobillo S, Joffe E, Lavery JA, et al. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era. Blood. 2021;137(1):39-48.

This feature is available to Subscribers Only

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only